Literature DB >> 23592673

Diet composition and activity level of at risk and metabolically healthy obese American adults.

Arlene L Hankinson1, Martha L Daviglus, Linda Van Horn, Queenie Chan, Ian Brown, Elaine Holmes, Paul Elliott, Jeremiah Stamler.   

Abstract

OBJECTIVE: Obesity often clusters with other major cardiovascular disease risk factors, yet a subset of the obese appears to be protected from these risks. Two obesity phenotypes are described, (i) "metabolically healthy" obese, broadly defined as body mass index (BMI) ≥ 30 kg/m(2) and favorable levels of blood pressure, lipids, and glucose; and (ii) "at risk" obese, BMI ≥ 30 with unfavorable levels of these risk factors. More than 30% of obese American adults are metabolically healthy. Diet and activity determinants of obesity phenotypes are unclear. We hypothesized that metabolically healthy obese have more favorable behavioral factors, including less adverse diet composition and higher activity levels than at risk obese in the multi-ethnic group of 775 obese American adults ages 40-59 years from the International Population Study on Macro/Micronutrients and Blood Pressure (INTERMAP) cohort. DESIGN AND METHODS: In gender-stratified analyses, mean values for diet composition and activity behavior variables, adjusted for age, race, and education, were compared between metabolically healthy and at risk obese.
RESULTS: Nearly one in five (149/775 or 19%) of obese American INTERMAP participants were classified as metabolically healthy obese. Diet composition and most activity behaviors were similar between obesity phenotypes, although metabolically healthy obese women reported higher sleep duration than at risk obese women.
CONCLUSIONS: These results do not support hypotheses that diet composition and/or physical activity account for the absence of cardiometabolic abnormalities in metabolically healthy obese.
Copyright © 2012 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23592673      PMCID: PMC3416914          DOI: 10.1002/oby.20257

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


INTRODUCTION

Obesity is associated with higher mortality risks, higher health care costs, impaired physical functioning, lower quality of life, and higher morbidity from major cardiovascular and noncardiovascular causes.[1-6] Obesity often clusters with other major cardiovascular disease (CVD) risk factors including prehypertension and hypertension, dyslipidemia, and impaired glucose tolerance[7, 8], yet a subset of the obese appears to be protected from these risks. Two obesity phenotypes have been described, 1) “metabolically healthy” obese and 2) “at risk” obese[9-11]. The metabolically healthy obese phenotype is broadly defined as body mass index (BMI) ≥ 30 kg/m2 and favorable levels of blood pressure, lipids, and glucose. According to data from the 1994–2004 National Health and Nutrition Examination Survey (NHANES)[12], more than 30% of the nearly 61 million obese American adults are metabolically healthy obese, defined as obese with no more than one cardiometabolic risk factor. With metabolically healthy defined as no adverse levels of cardiometabolic risk factors, 17 % of obese are metabolically healthy. Determinants of obesity phenotypes are unclear, particularly role of diet composition, i.e., intake measured either by food groups (food-based categories) or nutrients (macro-/micronutrients); and behaviors related to activity levels, i.e., sleep duration, television viewing time, other sedentary behavior, and physical activity[13]. To our knowledge, there are no population-based data on diet composition by obesity phenotype; aside from leisure time activity, behaviors related to activity levels have rarely been assessed in obesity phenotypes. Furthermore, obese phenotypes have rarely been investigated in ethnically diverse groups, including those with inordinately high prevalence rates of obesity and CVD risk factors. Here we present data on these matters for a multi-ethnic cohort of 2,195 adults ages 40–59 years from eight diverse U.S. population samples of the INTERMAP Study[14-16]. We hypothesized that metabolically healthy obese have more favorable behavioral factors, including less adverse diet composition and higher physical activity levels than at risk obese.

METHODS AND PROCEDURES

Participants

The International Population Study on Macro/Micronutrients and Blood Pressure (INTERMAP) is a cross-sectional investigation of the relation of dietary factors (foods/nutrients) and urinary metabolites to blood pressure[14, 16, 17]. It includes 4,680 men and women ages 40–59 from 17 diverse population samples, including 2,195 persons from eight diverse American population samples. Details about eligibility criteria and baseline demographic characteristics have been published[16]. Each sample was selected randomly from an age/gender stratified population list, to give approximately equal numbers of people in each of four 10-year age-gender groups (men ages 40–49 and 50–59; women ages 40–49 and 50–59). This study is based on 2,195 participants from US samples. Of these, non-obese persons (BMI < 30 kg/m2) were excluded, leaving a total of 775 obese American adults (398 men and 377 women), i.e., 35% of the American INTERMAP cohort, for analysis.

Data collection

Each participant attended the local INTERMAP research center on four occasions: two visits on consecutive days with a further two visits on consecutive days on average three weeks later. Whenever possible, one visit by each participant included a weekend day (or an equivalent rest day) according to work schedule. All data were collected by trained and certified staff using high quality standardized methods. The protocol was approved by the institutional review board at each research center and written consent was obtained from each participant.

Blood pressure and other data

Blood pressure of the seated participant was measured twice per visit (four different days) with a random zero sphygmomanometer after emptying the bladder and at least five minutes of rest in a quiet room. Pulse was measured three times per visit. At the first and third visit, height without shoes was measured using a vertically placed rule with the base at floor level and weight was measured using a balance beam or weighing scale. BMI was calculated as weight divided by height squared (kg/m2). Data on demographic and other factors, including education, sleep duration, television viewing time, leisure-time and work-related physical activity (usual hours per day spent sitting or doing light and moderate/heavy activity) smoking (current, former, or never smoker), family and previous medical history, current special diet, and medication use were collected by interviewer-administered questionnaire.

Dietary data

Dietary data were collected at each of the four visits by a trained certified interviewer using the in-depth multipass 24-hour recall method. All foods and beverages consumed in the previous 24 hours were recorded. To aid accurate recall, fresh foods of varied standardized portion sizes, food and drink models, containers of various types and sizes, and photographs were used. Interviewers used neutral probing techniques to check for completeness of items reported, and details such as brand names of foods, quantities, processing methods, additions in cooking and/or at table, and amounts left on plate[15, 16]. Dietary information was directly computerized with use of a program to guide on-screen coding. Nutrient intakes of participants were calculated from U.S. specific food tables. Daily alcohol consumption (amount and type of alcoholic beverage) over the previous seven days and, for abstainers, information on previous drinking were obtained by interview twice, at the first and third visits; these data were in addition to those on alcohol intake from the four 24-hour dietary recalls. Abstainers were those who reported no current alcohol consumption in the four dietary recalls, all others were considered current drinkers. 83 nutrient variables, including total energy intake and macro-/micronutrients were assessed. Food group analyses were performed using the Nutrition Data System for Research (NDSR) version 2.91from the Nutrition Coordinating Center (NCC) at the University of Minnesota[18]. The NDSR includes 9 generic food groups and 168 subgroups that were considered in these analyses. Based on NDSR groupings, INTERMAP investigators created 16 food groups and 42 food-based subgroups, concentrating on specific food subgroups including meat and fish, dairy, eggs, fruits, vegetables, and grains. The 34 nutrient variables and 14 food group variables selected for this analysis were those putatively associated with healthy diet composition. The food group variables are described in Appendix A. Both individual nutrient and food group variables were analyzed in regard to the outcomes of interest. [19, 20]
Appendix A

14 food group variables, adapted from Nutrition Data System for Research, Nutrition Coordinating Center University of Minnesota

Food Groups and SubgroupsDescription
Total fruits100% fruit juices and drinks, sweetened and unsweetened fruits, dried fruits
Fresh fruitsSubgroup of total fruits
Total vegetablesRaw, cooked (fresh, frozen, or canned), vegetarian meat substitutes, vegetable recipes
Total grainsBreads, rolls, biscuits, pancakes, ready to eat cereals, grains and flour
Nuts, nut butters, and legumesNuts, nut butters, mature dried beans and peas
Low fat dairy productsLess than 2% fat content dairy products-i.e., cream, cheese, ice creams, milk/cheese recipes, milk, yogurt, yogurt frozen, cocoa
Higher fat dairy products2% or more fat content dairy products (listed above)
Fish and seafoodFish and fish roe, shellfish
PoultryDomestic and wild fowl
Fresh meatsBeef, lamb, pork, veal, game
Processed meatsFresh and cured cold cuts, sausage
FatsAnimal fats, margarines, table spreads, oils, shortening, salad dressing
SweetsSugar, syrup, honey, jam, jelly, preserves, sweet sauces, candy
Sugar sweetened beveragesSweetened non-carbonated drinks (<100% juice), does not include artificially sweetened drinks

Urinary data

For the optimal assessment of dietary sodium, potassium, and total protein intake, two timed 24-hour urine specimens were collected; urinary sodium (Na), potassium (K), creatinine, urea (index of 24-hour total protein intake), and multiple other metabolites were measured[16]. Timed collections were started at the research center on the first and third visits, and completed at the center the following day. Urine aliquots were stored frozen at −20°C before being shipped frozen to a Central Laboratory in Leuven, Belgium, where analyses were performed with extensive internal and external quality control; further analyses were subsequently done at a Central Laboratory in London, England. Individual excretion values were calculated as the product of concentrations in the urine and urinary volume corrected to 24 hours. The average of the two excretion values was used.

Definition of obesity phenotypes

Since there are no uniform criteria to define obese phenotypes, an INTERMAP specific definition was developed. Metabolically healthy was defined as meeting all of the following criteria: favorable blood pressure (≤120/≤80 mm Hg) and no medication or special diet for hypertension; no physician diagnosis, medication, or special diet for other metabolic risk factors (i.e., diabetes and dyslipidemia); no prevalent cardiovascular disease. Any participant not meeting these criteria was classified as at risk obese.

Statistical analyses

Prevalence rates of metabolically healthy obese and at risk obese were calculated separately for the two genders and for the whole sample. Overall mean values for continuous descriptive variables (age, years of education, BMI, pulse) and proportions of categorical descriptive variables (% female, % nonWhite, % current drinkers, % current smokers, % with family history of hypertension) were calculated for metabolically healthy and at risk obese. Differences in overall mean values between the metabolically healthy and at risk obese were compared using t-tests; proportions were compared using chi-square analyses. All other analyses were done separately within gender groups. Means, adjusted for age, race, and education, were calculated for 14 food groups, 34 macro-/micronutrients, and 5 activity behavior variables. Data for food group variables were not normally distributed; adjusted means of log-transformed food group values were calculated and back transformed for presentation as geometric means. T-tests were used to compare adjusted means of metabolically healthy and at risk obese by gender. To address potential type I error from multiple comparisons of the 53 food group, nutrient, and activity variables, Bonferroni correction was performed; the corrected α level for significant results was 0.05/53=0.001. In a sensitivity analysis, all of the aforementioned analyses were repeated with the criteria for healthy obese also including nonsmoking. Analyses were done by the first author (A. Hankinson) with SAS statistical software, version 9.2 (SAS Inc, Cary, NC).

RESULTS

Prevalence and characteristics of obese phenotypes

Descriptive statistics for 775 obese American INTERMAP participants, stratified by gender, are shown in Table 1; 19% (149/775) met the definition of metabolically healthy obese. Prevalence of metabolically healthy obese was similar in men and women (20% and 19%, respectively). Compared with at risk obese, metabolically healthy obese adults were significantly younger; there were the following nonsignificant differences: lower BMI, higher proportion of nonWhite race/ethnicity (Black, Hispanic, Asian, and Native American), and lower prevalence of family history of hypertension. In sensitivity analysis with no smoking as an additional criterion for metabolically healthy obese, 127 of the 775 participants (16%) met all criteria; the remaining 648 were considered at risk obese. Results (not tabulated here) were nearly identical to the overall results.
Table 1

Descriptive statistics of at risk and metabolically healthy obese American adults, by gender – mean (standard deviation) or % (n)

Men (n=398)Women (n=377)

VariableAt risk (n=323)Metabolically healthy (n=75)At risk (n=303)Metabolically healthy (n=74)
Age, years*49.1 (5.3)48.2 (4.9)50.1 (5.3)46.0 (4.8)
% non White, (n)45.8 (148)44.0 (33)54.8 (166)63.5 (47)
Education, years14.7 (2.8)15.1 (2.8)13.7 (2.8)13.6 (2.9)
Weight, kg106.6 (16.4)103.2 (13.2)95.5 (16.3)90.1 (12.3)
Height, meters1.8 (0.1)1.8 (0.1)1.6 (0.1)1.6 (0.1)
Body mass index, kg/m234.6 (4.4)33.1 (3.3)36.4 (5.4)35.0 (4.4)
Pulse, beats/minute75.4 (10.2)72.0 (9.6)75.7 (9.7)76.4 (7.6)
Systolic blood pressure, mmHg*126.7 (11.6)112.2 (5.0)126.2 (13.5)109.7 (6.2)
Diastolic blood pressure, mmHg*79.5 (10.3)72.0 (4.7)75.0 (8.7)67.6 (6.2)
% Current drinkers, (n)73.1 (236)81.3 (61)57.4 (174)58.1 (43)
% Current smokers, (n)16.1 (52)13.3 (10)13.9 (42)16.2 (12)
% with family history of HTN, (n)68.1 (220)57.3 (43)76.6 (232)68.9 (51)

Abbreviations - HTN: hypertension

Metabolically healthy obese defined as BMI ≥ 30 kg/m2 and meeting all of the following criteria: blood pressure ≤120/≤80 mm Hg, no medication or special diet for hypertension, no physician diagnosis, medication, or special diet for cardiovascular disease (CVD) risk factors (i.e., diabetes and dyslipidemia),no prevalent CVD, and no special diet for weight loss or weight gain. Serum glucose and lipids were not measured.

Values significantly different for at risk obese compared to metabolically healthy obese (p-value <0.05) p-values calculated using t-test for means, chi-square test for proportions

Diet composition: Food groups and macro-/micronutrients

Fourteen food groups and 34 dietary macro-/micronutrients were compared between at risk and metabolically healthy obese phenotypes. There were no significant differences in food groups (Table 2) or nutrients (Table 3) between obesity phenotypes. In both genders, metabolically healthy obese reported nonsignificantly lower energy intake compared with at risk obese. There was no significant difference in type or amount of food group intake, including fruits and vegetables, grains, meats, fish, and sugar sweetened beverages across obesity phenotypes. In women, the metabolically healthy obese reported higher amounts of vegetable protein and starch and lower amounts of total protein (estimated from urinary urea) compared with at risk obese. These differences had p-values below 0.05, but did not meet the alpha level of significance adjusted for multiple comparisons. Intakes of other macro-/micronutrients, including total fat, protein, carbohydrate, fiber, iron, and alcohol were similar across the two obesity phenotypes for men and women.
Table 2

Food group intake, at risk and metabolically healthy obese American adults by gender -- adjusted geometric means

Men (n=398)Women (n=377)

Food group (g/1000kcal)At risk (n=323)Metabolically healthy (n=75)p-valueAt risk (n=303)Metabolically healthy (n=74)p-value
Total fruits119.499.80.34557.576.00.136
Fresh fruits38.050.30.13725.530.00.414
Total vegetables109.3106.10.686140.4139.30.921
Whole grains16.014.80.63915.514.40.664
Nuts, nut butters, legumes10.19.40.7577.410.20.189
Low fat dairy products22.420.40.82532.432.20.980
Other dairy products26.126.70.84432.131.90.973
Fish, seafood19.313.10.0729.012.60.179
Poultry21.018.80.45123.723.80.973
Fresh meats31.229.70.68428.021.10.027
Processed meats7.67.60.98910.411.00.744
Fats, oils15.516.20.57717.117.40.826
Snacks, sweets18.417.70.77813.514.20.701
Sugar sweetened beverages134.0129.80.822153.1120.90.118

Geometric means adjusted for age, race, and education; p-values calculated using t-test Significant α level with Bonferroni correction for multiple testing (0.05/53 diet and activity variables) = 0.001

A complete description of food group variables is given in Appendix A.

Table 3

Nutrient and energy intake in at risk and metabolically healthy obese American adults, by gender – adjusted means

Men (n=398)Women (n=377)

NutrientAt risk (n=323)Metabolically healthy (n=75)p-valueAt risk (n=303)Metabolically healthy (n=74)p-value
Energy intake, %kcal2687.52533.60.0821998.61981.20.811
Keys dietary lipid score38.637.90.53738.537.40.387
Total fat, %kcal34.634.10.60534.233.70.577
Cholesterol, mg/1000kcal142.8144.30.842145.2138.60.429
Omega-3 PFA, %kcal0.70.80.4120.80.80.955
Omega-6 PFA, %kcal6.46.40.9666.46.40.746
Total SFA, %kcal11.311.00.44211.211.00.534
Total MFA, %kcal12.912.80.69312.712.40.468
MFA 18:1, %kcal12.312.10.68012.011.80.592
Total PFA, %kcal7.07.00.9657.07.10.813
Total TFA, %kcal2.11.90.2422.02.00.832
Total Protein, %kcal15.915.80.87215.815.50.461
Animal Protein, %kcal10.810.90.81110.910.20.120
Vegetable Protein, %kcal4.84.70.4634.85.10.018
Total Protein from urea N, g/day92.991.90.74971.165.10.020
Sugar from beverages, %kcal5.76.00.7425.64.70.250
Sugar from fruit, %kcal2.93.30.2683.22.90.412
Total Sugar, %kcal25.126.70.14427.226.70.663
Starch, %kcal22.021.50.43921.623.20.025
Total Carbohydrates, %kcal47.148.10.29848.850.00.299
Alcohol, %kcal3.22.20.1371.71.20.454
Iron, mg/1000 kcal7.57.10.2377.47.60.552
Heme iron, mg/1000 kcal0.60.60.9850.60.50.093
Non-heme iron, mg/1000 kcal6.96.60.2346.87.10.388
Total fiber, g/1000 kcal8.28.30.7298.38.70.289
Calcium, mg/1000 kcal350.6344.20.701363.7378.10.458
Magnesium, mg/1000 kcal140.5136.00.308137.9141.70.404
Phosphorus, mg/1000 kcal587.7577.00.452584.2597.50.427
Vitamin A, IU/1000 kcal3004.13257.20.4123739.74282.60.199
Vitamin C, mg/1000 kcal46.251.70.21249.349.90.889
Vitamin E, mg/1000 kcal4.24.40.5434.44.50.771
Urinary Na, mmol/day204.6190.50.086165.6152.80.083
Urinary K, mmol/day67.967.50.89052.348.90.152
Urinary Na/K ratio3.33.20.5053.53.40.428

Means adjusted for age, race, and education; p-values calculated using t-test

Significant α level with Bonferroni correction for multiple testing (0.05/53 diet and activity variables) = 0.001

Abbreviations: PFA-polyunsaturated fatty acids, MFA-monounsaturated fatty acids, SFA-saturated fatty acids, TFA-trans fatty acids, Na-sodium, K-potassium

Activity behaviors: Sleep, television viewing time, other sedentary activity, physical activity levels

There were no significant differences in sleep duration, television viewing time, other sedentary activity, and physical activity levels between obesity phenotypes in men (Table 4). In women, metabolically healthy obese reported significantly higher sleep duration than at risk obese (7.6 hours/day vs. 7.0 hours/day); there were no significant differences in other activity behaviors.
Table 4

Activity levels in at risk and metabolically healthy obese American adults, by gender – adjusted means

Men (n=398)Women (n=377)

VariableAt risk (n=323)Metabolically healthy (n=75)p-valueAt risk (n=303)Metabolically healthy (n=74)p-value
Sleeping, hrs/day7.16.80.1037.07.60.001
TV viewing time, hrs/day2.62.50.5482.52.50.728
Other sedentary activity, hrs/day7.27.50.4757.36.70.280
Light activity, hrs/day3.63.70.9153.94.20.274
Moderate-heavy activity, hrs/day3.43.40.9703.33.00.515

Means adjusted for age, race, and education; p-values calculated using t-test

Significant α level with Bonferroni correction for multiple testing (0.05/53 diet and activity variables) = 0.001

DISCUSSION

In this population-based study of 775 obese American middle-aged adults, 19% (nearly 1 in 5) met criteria for metabolically healthy obese, defined by favorable levels of cardiometabolic risk factors. This study is the first, to our knowledge, to compare diet composition between obesity phenotypes. Diet composition, measured as intake of food groups and macro-/micronutrients, and activity behaviors (e.g., television viewing time, other sedentary activity, and physical activity levels) were similar between obesity phenotypes, with the exception of longer sleep duration in metabolically healthy obese women. Other factors, including BMI, energy intake, and sociodemographic characteristics were similar between obesity phenotypes. These results prevailed with no smoking as an additional criterion for metabolically healthy obese. Our results indicate that diet composition and activity behaviors do not explain the absence of cardiometabolic abnormalities in metabolically healthy obese adults. The 19% prevalence rate for the metabolically healthy obese phenotype observed in the present study is lower than the 23–32% reported in previous studies.[11, 12, 21] Our lower prevalence rate may be explained by our more strict definition for the metabolically healthy obese phenotype, particularly our criteria for favorable blood pressure (≤ 120/80 mm Hg and no antihypertensive medications). Other studies with blood pressure in the definition of metabolically healthy obesity used a threshold of 140/90 or 130/85 mmHg, i.e., inclusive of persons with prehypertension[22] in the metabolically healthy obese group. Also, some definitions included one cardiometabolic abnormality in the definition of the metabolically healthy obese phenotype. A recent NHANES report estimated the prevalence of metabolically healthy American obese to be 32% based on a definition including one cardiometabolic abnormality; prevalence was 17% when metabolically healthy was defined as absence of any cardiometabolic abnormalities, i.e., a rate similar to ours. [12] No significant associations were observed between obesity phenotypes and diet composition. This absence of significant association between diet composition and obesity phenotypes is relevant in the light of compelling observational study and clinical trial evidence that a healthy diet may be associated with the metabolically healthy obese phenotype regardless of diet quantity (energy intake). For example, in overweight/obese adults, the Diabetes Control and Complications Trial and the Finnish Diabetes Prevention Study both reported a 58% reduction in incident diabetes through diet and activity interventions with modest (<10%) weight loss.[23, 24] The OmniHeart trial demonstrated beneficial effects on blood pressure, high density lipoprotein cholesterol (HDL-C), and triglycerides with isocaloric replacement of carbohydrates by proteins or unsaturated fat in adults with mean BMI of 30.2 kg/m2.[25] INTERMAP and other observational studies have shown similar associations between diet composition and CVD risk factor levels. In particular, prior work in the INTERMAP cohort has demonstrated an inverse relationship to blood pressure of several macro-/micronutrients, including calcium, magnesium, phosphorous, total and non heme iron, vegetable protein, and omega-3 fatty acids.[26-31] Of these nutrients, in the present study only vegetable protein was noted to be higher in the metabolically healthy obese; the finding prevailed only in women and the p-value was not statistically significant after adjustment for multiple comparisons. While no study, to our knowledge, has reported sleep duration or sedentary behaviors in obesity phenotypes, a few cross-sectional studies have investigated associations between physical activity levels and obesity phenotypes, with contradictory results. Self-reported activity data showed associations between higher activity and the metabolically healthy obesity phenotype, while objective physical activity data did not.[12, 32] Results of the current study for activity levels are concordant with objective physical activity data. Among obese women, the metabolically healthy reported 0.6 hours longer sleep duration than at risk obese. Although shorter sleep duration has often been associated with obesity in cross-sectional and prospective studies,[33, 34] this is the first report of an association with the at risk obesity phenotype. It is hypothesized that shorter sleep duration and obesity may be linked through neuroendocrine changes that influence appetite and favor a positive caloric balance,[34] or through behaviors often correlated with short sleep duration, such as television viewing time and consumption of high energy foods.[35, 36] These hypotheses are not likely to explain the observed association with obesity phenotypes in our cohort of American INTERMAP women, since energy intake, television viewing time, and diet composition were similar in at risk and metabolically healthy obese women. While measures of sedentary behavior were not statistically different between obesity phenotypes, metabolically healthy obese men reported fewer hours of television viewing time and metabolically healthy obese women reported less sedentary activity than their at risk obese counterparts, suggesting less sedentary behavior in the metabolically healthy obese compared with at risk obese. Mean age of metabolically healthy obese was nearly three years younger than the at risk obese, consistent with findings from NHANES.[12] Other studies comparing mean age between obesity phenotypes reported discrepant findings, showing significantly older age of healthy obese,[12, 37] or no significant difference in age.[38-41] Our study has several strengths, including our strict definition of metabolically healthy obese and the high quality diet data, meticulously measured with four separate in-depth multi pass 24-hour recalls. We also recorded several measures of activity behavior, including sleep duration, two measures of sedentary behavior, and physical activity levels of varying intensities (light and moderate to vigorous). We corrected for multiple testing using a conservative method to adjust the alpha level, which likely inflated type II (false negative) error. Our study is limited by its cross sectional design, which precludes assessment of relationships between antecedent behavioral factors and obesity phenotypes. Another limitation needing emphasis is the absence of INTERMAP data on blood glucose and lipids for our obesity phenotype classification. Finally, although diet data was collected with rigor, recall bias of dietary data is likely. In conclusion, nearly 1 in 5 (19%) of obese INTERMAP middle-aged American adult participants were classified as metabolically healthy, a prevalence rate similar to that of previous reports using similar definitions. Diet composition, measured by food group and macro-/micronutrient intake, was not associated with obesity phenotype. While sleep duration was associated with obesity phenotype in women, other activity behaviors factors, including television viewing time, other sedentary activity, and physical activity levels were not significantly related to obesity phenotype. These results do not support hypotheses that diet composition and physical activity account for absence of cardiometabolic abnormalities in metabolically healthy obese adults.
  39 in total

1.  Background to the INTERMAP study of nutrients and blood pressure.

Authors:  D G Beevers; J Stamler
Journal:  J Hum Hypertens       Date:  2003-09       Impact factor: 3.012

2.  Relation of urinary calcium and magnesium excretion to blood pressure: The International Study Of Macro- And Micro-nutrients And Blood Pressure and The International Cooperative Study On Salt, Other Factors, And Blood Pressure.

Authors:  Hugo Kesteloot; Ioanna Tzoulaki; Ian J Brown; Queenie Chan; Anisha Wijeyesekera; Hirotsugu Ueshima; Liancheng Zhao; Alan R Dyer; Robert J Unwin; Jeremiah Stamler; Paul Elliott
Journal:  Am J Epidemiol       Date:  2011-05-30       Impact factor: 4.897

3.  What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

Authors:  M Brochu; A Tchernof; I J Dionne; C K Sites; G H Eltabbakh; E A Sims; E T Poehlman
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

Review 4.  Obesity and health-related quality of life.

Authors:  K R Fontaine; I Barofsky
Journal:  Obes Rev       Date:  2001-08       Impact factor: 9.213

5.  Relationship between obesity, insulin resistance, and coronary heart disease risk.

Authors:  Fahim Abbasi; Byron William Brown; Cindy Lamendola; Tracey McLaughlin; Gerald M Reaven
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  INTERMAP: the dietary data--process and quality control.

Authors:  B Dennis; J Stamler; M Buzzard; R Conway; P Elliott; A Moag-Stahlberg; A Okayama; N Okuda; C Robertson; F Robinson; S Schakel; M Stevens; N Van Heel; L Zhao; B F Zhou
Journal:  J Hum Hypertens       Date:  2003-09       Impact factor: 3.012

Review 8.  INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary).

Authors:  J Stamler; P Elliott; B Dennis; A R Dyer; H Kesteloot; K Liu; H Ueshima; B F Zhou
Journal:  J Hum Hypertens       Date:  2003-09       Impact factor: 3.012

9.  Years of life lost due to obesity.

Authors:  Kevin R Fontaine; David T Redden; Chenxi Wang; Andrew O Westfall; David B Allison
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

Review 10.  Metabolic and body composition factors in subgroups of obesity: what do we know?

Authors:  Antony D Karelis; David H St-Pierre; Florence Conus; Remi Rabasa-Lhoret; Eric T Poehlman
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

View more
  42 in total

1.  Dietary inflammatory potential and risk of mortality in metabolically healthy and unhealthy phenotypes among overweight and obese adults.

Authors:  Yong-Moon Mark Park; Moon Kyung Choi; Seong-Su Lee; Nitin Shivappa; Kyungdo Han; Susan E Steck; James R Hébert; Anwar T Merchant; Dale P Sandler
Journal:  Clin Nutr       Date:  2018-04-16       Impact factor: 7.324

2.  A healthy lifestyle pattern is associated with a metabolically healthy phenotype in overweight and obese adults: a cross-sectional study.

Authors:  Farah Naja; Leila Itani; Mona P Nasrallah; Hassan Chami; Hani Tamim; Lara Nasreddine
Journal:  Eur J Nutr       Date:  2019-07-30       Impact factor: 5.614

3.  Metabolically Healthy Obesity Is Not Associated with Food Intake in White or Black Men.

Authors:  Ruth W Kimokoti; Suzanne E Judd; James M Shikany; P K Newby
Journal:  J Nutr       Date:  2015-09-30       Impact factor: 4.798

4.  Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity.

Authors:  T Geng; W Hu; M H Broadwater; J M Snider; J Bielawski; S B Russo; J H Schwacke; J Ross; L A Cowart
Journal:  Diabetologia       Date:  2013-07-03       Impact factor: 10.122

5.  Food intake does not differ between obese women who are metabolically healthy or abnormal.

Authors:  Ruth W Kimokoti; Suzanne E Judd; James M Shikany; P K Newby
Journal:  J Nutr       Date:  2014-10-08       Impact factor: 4.798

6.  Sugar-sweetened beverages and prevalence of the metabolically abnormal phenotype in the Framingham Heart Study.

Authors:  Angela K Green; Paul F Jacques; Gail Rogers; Caroline S Fox; James B Meigs; Nicola M McKeown
Journal:  Obesity (Silver Spring)       Date:  2014-03-08       Impact factor: 5.002

7.  Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

Authors:  Helen Vlassara; Weijing Cai; Elizabeth Tripp; Renata Pyzik; Kalle Yee; Laurie Goldberg; Laurie Tansman; Xue Chen; Venkatesh Mani; Zahi A Fayad; Girish N Nadkarni; Gary E Striker; John C He; Jaime Uribarri
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

8.  Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes.

Authors:  Y-M Park; S E Steck; T T Fung; J Zhang; L J Hazlett; K Han; A T Merchant
Journal:  Int J Obes (Lond)       Date:  2016-06-24       Impact factor: 5.095

Review 9.  Metabolically healthy obesity: definitions, determinants and clinical implications.

Authors:  Catherine M Phillips
Journal:  Rev Endocr Metab Disord       Date:  2013-09       Impact factor: 6.514

Review 10.  Metabolically healthy obesity: facts and fantasies.

Authors:  Gordon I Smith; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.